The action mechanism of zinc(II) complexes with insulinomimetic activity in rat adipocytes

Life Sciences

Volumn 75, Issue 6, 2004, Pages 741-751

  Yoshikawa, Yutaka ^a   Ueda, Eriko ^a   Kojima, Yoshitane ^a   Sakurai, Hiromu ^b  

^a Osaka Prefecture University   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Action mechanism; Adipocyte; Diabetes; Zn(II) complex

Indexed keywords

CILOSTAMIDE; CYTOCHALASIN B; FATTY ACID; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR; PHOSPHODIESTERASE; WORTMANNIN; ZINC COMPLEX;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; DRUG UPTAKE; FATTY ACID METABOLISM; GLUCOSE TRANSPORT; INSULINOMIMETIC ACTIVITY; MALE; NONHUMAN; RAT;

ADIPOCYTES; ANDROSTADIENES; ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EPINEPHRINE; FATTY ACIDS, NONESTERIFIED; INSULIN; MALE; MALTOSE; ORGANOMETALLIC COMPOUNDS; PICOLINIC ACIDS; QUINOLONES; RATS; RATS, WISTAR; SULFATES; THREONINE; ZINC;

ANIMALIA;

EID: 2542456412     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.02.006     Document Type: Article

References (36)

1. Bandyopadhyay G., Standaert M.L., Zhao L., Yu B., Avignon A., Galloway L., Karnam P., Moscat J., Farese R.V. Activation of protein kinase C (alpha, beta, and zeta) by insulin in 3T3/L1 cells. Transfection studies suggest a role for PKC-zeta in glucose transport. J. Biol. Chem. 272:1997;2551-2558
2. Chen M.D., Liou S.J., Lin P.Y., Yang V.C., Alexander P.S., Lin W.H. Effects of zinc supplementation on the plasma glucose level and insulin activity in genetically obese (ob/ob) mice. Biol. Trace Elem. Res. 61:1998;303-311
3. Coulston L., Dandona P. Insulin-like effect of zinc on adipocytes. Diabetes. 29:1980;665-667
4. 2+) stimulate glucose transport activity by post-insulin receptor kinase mechanism in rat adipocytes. J. Biol. Chem. 264:1989;16118-16122
5. Fugono J., Fujimoto K., Yasui H., Kawabe K., Yoshikawa Y., Kojima Y., Sakurai H. Metallokinetic study of zinc in the blood of normal rats given insulinomimetic zinc(II) complexes and improvement of diabetes mellitus in type 2 diabetic GK rats by their oral administration. Drug Metabol. Pharmacokin. 17:2002;340-347
6. Ghosh R., Mukherjee B., Chatterjee M. A novel effect of selenium on streptozotocin-induced diabetic mice. Diabetes Res. 25:1994;165-171
7. Hansen P.A., Corbett J.A., Holloszy J.O. Phorbol esters stimulate muscle glucose transport by a mechanism distinct from the insulin and hypoxia pathways. Am. J. Physiol. 273:1997;E28-E36
8. Hidaka H., Endo T. Selective inhibitors of three forms of cyclic nucreotide phosphodiesterase-basic and potential clinical applications. Adv. Cyc. Nucl. Pro. Phospho. Res. 16:1984;245-259
9. Horlington M., Watson P.A. Inhibition of 3′, 5′-cyclic-AMP phosphodiesterase by some platelet aggregation inhibitors. Biochem. Pharmacol. 19:1970;955-956
10. James M.M., Charles S.C. The mechanism of the insulin-like effects of ionic zinc. J. Biol. Chem. 257:1982;4362-4368
11. John A.C. Effects of cytochalasin and phallodin on actin. Mol. Cell. Biol. 105:1987;1473-1477
12. Jung C.Y., Lee W. Glucose transporters and insulin action: some insights into diabetes management. Arch. Pharm. Res. 22:1999;329-334
13. Kasuga M., Zick Y., Blith D.L., Karlsson F.A., Haring H.U., Kahn C.R. Insulin stimulation of phosphorelation of the beta subunit of the insulin receptor. Formation of both phosphoserine and phosphotyrosine. J. Biol. Chem. 257:1982;9891-9894
14. Kasuga M., Izumi T., Tobe K., Shiba T., Momomura K., Tashiro-Hashimoto Y., Kadowaki T. Sabstrates for insulin-receptor kinase. Diabetes Care. 13:1990;317-326
15. King H., Aubert R.E., Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 21:1998;1414-1431
16. Rubenstein A.H., Levin N.W., Elliott G.A. Hyperglycemia induced by manganese. Nature. 194:1962;188-189
17. Kitamura T., Kitamura Y., Kuroda S., Hino Y., Ando M., Kotani K., Konishi H., Matsuzaki H., Kikkawa U., Ogawa W., Kasuga M. Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase (PDE) 3B by the serine-threonine kinase. Akt. Mol. Cell. Biol. 19:1999;6286-6296
18. Kotani K., Ogawa W., Matsumoto M., Kitamura T., Sakaue H., Hino Y., Miyake K., Sano W., Akimoto K., Ohno S., Kasuga M. Requirement of atypical protein kinase clambda for insulin stimulation of glucose uptake but not Akt activation in 3T3-L1 adipocytes. Mol. Cell. Biol. 18:1998;6971-6982
19. Monreal J.I., Viader C., Perez-Barquero C., Lopez-Moratalla N., Pablo P., Santiago E. Insulin-receptor interactions. Possible involvement of metals. Revista Espanpla De Fisiologia. 43:1987;133-140
20. Nakai M., Watanabe H., Fujisawa C., Kakegawa H., Satoh T., Takada J., Matsushita R., Sakurai H. Mechanism on insulin-like action of vanadyl sulfate: studies on interaction between rat adipocytes and vanadium compounds. Biol. Pharm. Bull. 18:1995;719-725
21. Okada T., Sakuma L., Fukui Y., Hazeki O., Ui M. Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. J. Biol. Chem. 269:1994;3563-3567
22. Okada T., Kawano Y., Sakakibara T., Hazeki O., Ui M. Essential role of phosphatidylinositol 3-kinase in insulin-induced Glucose transport and antilipolysis in rat adipocytes. J. Biol. Chem. 269:1994;3568-3573
23. Percival M.D., Yeh B., Falgueyret J.P. Zinc dependent activation of camp-specific phosphodiesterase (PDE4A). Biochem. Biophys. Res. Commun. 241:1997;175-180
24. Richard S., Pasquale P.V., Vincent H.S., Edward B., Eve E.S., William J.G., Debra L.O., Arthur A.P., David G.H. Design of a selective insulin receptor tyrosine kinase inhibitor and its effect on glucose uptake and metabolism in intact cells. Richard S. Biochem. 28:1984;5694-5701
25. Ronit I., Oksana K., David G., Hagit E.F. Inhibition of glycogen synthase kinase-3β by bivalent zinc ions: insight into the insulin-mimetic action of zinc. Biochem. Biophys. Res. Commun. 295:2002;102-106
26. Sakurai H., Kojima Y., Yoshikawa Y., Kawabe K., Yasui H. Antidiabetic vanadium(IV) and zinc(II) complexes. Coord. Chem. Rev. 226:2002;187-198
27. Sakurai H. A new concept: The use of vanadium complexes in the treatment of diabetes mellitus. Chem. Rec. 2:2002;237-248
28. Schwarz K., Mertz W. Chromium(III) and the glucose tolerance factor. Arch. Biochem. Biophys. 85:1959;292-295
29. Shechter Y., Karlish S.J.D. Insulin-like stimulation of glucose oxidation in rat adipocytes by vanadyl (IV) ions. Nature. 284:1980;556-559
30. Shisheva A., Gefel D., Schechter Y. Insulin-like effects of zinc ion in vitro and in vivo. Diabetes. 41:1992;982-988
31. Song M.K., Rosenthal M.J., Hong S., Harris D.M., Hwang I., Yip I., Golub M.S., Ament M.E., Go V.L.W. Synergistic antidiabetic activities of zinc, cyclo(His-Pro), and arachidonic acid. Metabolism. 50:2001;53-59
32. Ueda E., Yoshikawa Y., Ishino Y., Sakurai H., Kojima Y. Potential insulinomimetic agents of zinc(II) complexes with picolinamide derivatives: preparation of complexes, in vitro and in vivo studies. Chem. Pharm. Bull. 50:2002;337-340
33. Underwood E.J. In trace elements in human and animal nutrition. 4th ed. 1977;230-245 Academic Press, New York. Chap. 8
34. 4) coordination mode. Chem. Lett. 2000;874-875
35. 2) coordination mode. Chem. Pharm. Bull. 49:2001;652-654
36. Yoshikawa Y., Ueda E., Kawabe K., Miyake H., Takino T., Sakurai H., Kojima Y. Development of new insulin-mimetic zinc (II) complexes with picolinic acid derivatives: structure, in vitro, and in vivo studies. J. Biol. Inorg. Chem. 7:2002;68-73